San Martino Hospital, Genoa

Participant

Prof. Matteo Bassetti, Full Professor

Matteo Bassetti is Head of the Infectious Diseases Clinic of the Policlinico San Martino University Hospital in Genoa and Full Professor of Infectious Diseases of the University of Genoa, Italy. Dr Bassetti studied at the University of Genoa School of Medicine and continued his medical education at the Yale University School of Medicine, New Haven, USA with an Infectious Diseases fellowship.

Dr Bassetti is president of the Italian Society of Anti-infective Therapy (SITA) and member of executive committee for the battle against antimicrobial resistance of the Italian Minister of Health (PNCAR). He is co-chair of the Intra-abdominal Infections Study Group of the International Society of Chemotherapy (ISC). He is member-elected (2018-2022) of International Council of the Immunocompromised Host Society (ICHS). From 2019 he is member of the council of International Sepsis Forum (ISF). He serves on the editorial board of several prestigious international journals. Author or co-author of 660 papers (H index 70; 21000 citations) published in International peer-review journals and several chapter’s book on antibiotic therapy, fungal infections, antimicrobial resistances, infections in immunocompromised patients and critically ill patients.


Additional person involved in the project

Antonio Di Biagio, MD

Antonio Di Biagio since 2002 is an Infectious Disease specialist in the Infectious Diseases Clinic of the San Martino Polyclinic Hospital in Genoa. The main research interests focus on HIV / AIDS, tuberculosis and tropical medicine. He is the author of over 200 scientific articles published in peer-reviewed journals; principal investigator, sub-investigator in over 100 phase II, III and IV trials of antiretroviral drugs and antibiotics. He is adjunct professor of Infectious Diseases, School of Medical and Pharmaceutical Sciences of the University of Genoa. Dr. Di Biagio sits on the steering committee of PENTA (Pediatric Network Treatment AIDS) and on the scientific committee of CISAI (Italian group of adverse effects in Antiretroviral treatment), ICONA (Italian Cohort of Naïve Antiretroviral) and ARCA (Antiretroviral Resistance Cohort). Dr. Di Biagio is a member of the writing committee of the Italian guidelines on the management of patients with HIV / AIDS. Finally, he is a member of the International AIDS Society, the European AIDS Society and the Italian Society of Infectious Diseases